Healthcare stocks in Australia

Intrinsic value and value investing analysis for healthcare stocks in Australia.

11 companies

Companies

• TLX - Telix Pharmaceuticals Ltd ADR: overvalued, -254% margin of safety
• MESO - Mesoblast Ltd ADR: overvalued, -307% margin of safety
• CUVL - Clinuvel Pharmaceuticals Ltd ADR: undervalued, +57% margin of safety
• KZIA - Kazia Therapeutics Limited ADR: not valued
• ATHE - Alterity Therapeutics Ltd ADR: no published value
• IXHL - Incannex Healthcare Inc: no published value
• IMMP - Immutep Limited ADR: undervalued, +68% margin of safety
• RADX - Radiopharm Theranostics Ltd ADR: not valued
• IMRN - Immuron Limited ADR: undervalued, +75% margin of safety
• GELS - Gelteq Ltd: not valued
• PPCB - Propanc Biopharma Inc: no published value